No major variations were observed in plasma IGF-1 concentrations between patients in the OSAHS and control groups (SMD=-0.14, 95%CI= -1.01–0.72, P=0.745) according to a subgroup analysis of case-control studies (Table 4). This evidence concerns the gene IGF1 and obstructive sleep apnea syndrome.